Year, total population | Procedure | Number clinically detected | tTGA positive in screening | EmA positive in screening | Biopsy-proven cases in screening | Overall frequency of biopsy proven CD | Patients with CD and tTGA seropositive individuals |
---|---|---|---|---|---|---|---|
2002, 2815 | Serum sampling | ||||||
2004, 2815 | Recording of detected CD. First serologic analysis | 25 | 48 | 43 | 35 | 60 | 69a |
2005, 2216 | Recording of detected CD. Second serologic screening | 1 | 6 | 4 | 5b | 6 | 7 |
Overall prevalence, N = 2815 | 0.92% (26/2815) | 1.92% (54/2815) | 1.70% (47/2815) | 1.42% (40/2815) | 2.34% (66/2815) | 2.70% (76/2815) | |
95% confidence intervals | 0.57–1.27% | 1.41–2.43% | 1.22–2.18% | 0.98–1.86% | 1.78–2.90% | 2.10–3.30% |